Market Tracker

04/27 8:33am ET

Incyte Corp (NASDAQ:INCY)

123.08
Delayed Data
As of Apr 26
 -1.31 / -1.05%
Today’s Change
68.03
Today|||52-Week Range
153.15
+22.75%
Year-to-Date

Today’s Trading

Previous close124.39
Today’s open124.68
Day’s range122.32 - 125.47
Volume1,151,735
Average volume (3 months)2,246,427
Market cap$25.2B
Dividend yield--
Data as of 04/26/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-140.96%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+46.70%
P/E ratio227.9
Price/Sales17.60
Price/Book55.41

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+0.18+0.15%
ZTSZoetis Inc+0.45+0.82%
VRTXVertex Pharmaceutica...-0.93-0.79%
BAXBaxter International...+2.38+4.47%
Data as of 8:47am ET, 04/27/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.91
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts